[1]翟豫疆,苏 军,梁丽丽,等.滋阴利肺汤治疗肺结核合并慢性阻塞性肺疾病疗效及对患者肺泡巨噬细胞分泌细胞因子水平的影响[J].陕西中医,2021,(8):1041-1044.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.013]
　ZHAI Yujiang,SU Jun,LIANG Lili,et al.Effect of Ziyin Lifei decoction in the auxiliary treatment of pulmonary tuberculosis patients with chronic obstructive pulmonary disease and its effect on the secretion of cytokines by alveolar macrophages[J].,2021,(8):1041-1044.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.013]
点击复制

滋阴利肺汤治疗肺结核合并慢性阻塞性肺疾病疗效及对患者肺泡巨噬细胞分泌细胞因子水平的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年8期
页码:
1041-1044
栏目:
临床研究
出版日期:
2021-08-05

文章信息/Info

Title:
Effect of Ziyin Lifei decoction in the auxiliary treatment of pulmonary tuberculosis patients with chronic obstructive pulmonary disease and its effect on the secretion of cytokines by alveolar macrophages
作者:
翟豫疆1; 苏 军1; 梁丽丽2; 刘 帅3
(1.新疆医科大学附属中医医院,新疆 乌鲁木齐 830011; 2.河南省胸科医院,河南 郑州410100; 3.河南中医药大学,河南 郑州450046)
Author(s):
ZHAI Yujiang; SU Jun; LIANG Lili; Liu Shuai
(Affiliated Hospital of Traditional Chinese Medicine,Xinjiang Medical University,Urumqi 830011,China)
关键词:
肺结核;  慢性阻塞性肺疾病;  滋阴利肺汤;  肺泡巨噬细胞;  肿瘤坏死因子-α
Keywords:
Tuberculosis;  Chronic obstructive pulmonary disease;  Ziyin Lifei decoction;  Alveolar macrophages;  Tumor necrosis factor-α
分类号:
R 521
DOI:
DOI:10.3969/j.issn.1000-7369.2020.08.013
文献标志码:
A
摘要:
目的:研究滋阴利肺汤辅助治疗肺结核合并慢性阻塞性肺疾病患者效果观察及对肺泡巨噬细胞(AM)分泌细胞因子水平的影响。方法:选取肺结核合并慢性阻塞性肺疾病患者106例,随机分为对照组、观察组,对照组53例,采用常规西医治疗,观察组53例,采用常规西药联合滋阴利肺汤辅助治疗。比较两组治疗前后症状积分,临床疗效,两组治疗前后体液免疫、AM分泌细胞因子水平及不良反应。结果:两组治疗前咳嗽、咳痰、胸闷、气喘积分及总积分比较,差异无统计学意义(P>0.05); 两组治疗后上述积分均降低,观察组低于对照组(P<0.05)。观察组临床总有效率高于对照组(P<0.05)。两组治疗后CD4+T淋巴细胞占比、CD4+/CD8+均升高,观察组高于对照组,CD8+T淋巴细胞占比均降低,观察组低于对照组(P<0.05)。两组治疗前AM分泌白介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)、白介素-8(IL-8)、白介素-6(IL-6)水平比较,差异无统计学意义(P>0.05); 治疗后两组上述因子水平均降低,观察组低于对照组(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:滋阴利肺汤辅助治疗肺结核合并慢性阻塞性肺疾病可改善患者临床症状及疗效,降低AM分泌炎性因子水平,增强体液免疫。
Abstract:
Objective:To study the effect of Ziyin Lifei decoction in adjuvant treatment of pulmonary tuberculosis patients with chronic obstructive pulmonary obstruction and its effect on the level of cytokine secreted by alveolar macrophages(AM).Methods:A total of 106 patients with pulmonary tuberculosis and chronic obstructive pulmonary disease were randomly divided into control group and observation group.The 53 cases in the control group were treated with conventional western medicine,and the 53 cases in the observation group were treated with conventional western medicine combined with Ziyin Lifei decoction adjuvant therapy.The symptom scores of the two groups before and after treatment were compared.The clinical efficacy of the two groups was compared.The humoral immunity and secretion of cytokines by AM of the two groups before and after treatment were compared.The adverse reactions of the two groups was compared.Results:There were no significant differences in the scores of cough,sputum,chest tightness,asthma,and total scores of the two groups before treatment(P>0.05).The scores of the two groups were reduced after treatment,which of and the observation group were lower than those of the control group(P<0.05).The total clinical effective rate of the observation group was higher than that of the control group(P<0.05).The ratio of CD4+ T lymphocytes and CD4+/CD8+ of the two groups were increased(P<0.05),which of and the observation group were higher than those of the control group(P<0.05).The ratio of CD8+ T lymphocytes of the two groups were decreased(P<0.05),which of and the observation group was lower than that of the control group(P<0.05).There were no significant differences in the levels of interleukin-1β(IL-1β),tumor necrosis factor-α(TNF-α),interleukin-8(IL-8)and interleukin-6(IL-6)secreted by AM(P>0.05),which were reduced of the two groups after treatment,which of and the observation group were lower than those of the control group(P<0.05).There were no significant differences in the incidence of adverse reactions of the two groups(P>0.05).Conclusion:Ziyin Lifei decoction can improve the clinical symptoms and curative effect of patients with pulmonary tuberculosis combined with COPD,reduce the level of inflammatory factors secreted by AM,enhance humoral immunity.

参考文献/References:

[1] Bonnevie T,Elkins M.Chronic obstructive pulmonary disease[J].J Physiother,2020,66(1):3-4.
[2] Kaplan G.Tuberculosis control in crisis-causes and solutions[J].Prog Biophys Mol Biol,2020(152):6-9.
[3] 李婧辰,张 梅,李镒冲,等.我国40岁及以上人群慢性呼吸系统疾病症状流行现况及影响因素研究[J].中华流行病学杂志,2018,39(6):786-791.
[4] 任郭侠,赵 琳.滋阴利肺汤辅助治疗老年COPD合并肺结核的临床疗效及对肺功能、炎性因子的影响[J].中医药导报,2019,340(18):84-87.
[5] Beirne SL,Kikkers SA,Oromendia C,et al.Alveolar macrophage immunometabolism and lung function impairment in smoking and chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2020,201(6):735-739.
[6] 董碧蓉.呼吸疾病[M].北京:人民卫生出版社,2008:52-54.
[7] 陈园桃.中医病证诊疗常规[M].南京:东南大学出版社,2008:75-76.
[8] 中华中医药学会.中医内科常见病诊疗指南-中医病症部分[M].北京:中国中医药出版社,2008:87-89.
[9] 吴银根.常见肺系疾病的中医预防和护养[M].上海:复旦大学出版社,2013:80-84.
[10] Zhovanyk NV,Korshynska MI.Interaction between clinical and psychological changes among patients with chronic obstructive pulmonary disease and pulmonary tuberculosis co-morbidity[J].Wiad Lek,2019,72(4):635-638.
[11] 陈辅萍.慢性阻塞性肺疾病并发感染性肺炎危险因素分析[J].陕西医学杂志,2020,49(1):102-104.
[12] Guiedem E,Ikomey GM,Nkenfou C,et al.Chronic obstructive pulmonary disease(COPD):Neutrophils,macrophages and lymphocytes in patients with anterior tuberculosis compared to tobacco related COPD[J].BMC Res Notes,2018,11(1):192.
[13] 杨红丽,黎秋芬,徐力超.慢性阻塞性肺疾病合并肺结核患者血清细胞因子水平变化与意义研究[J].实用心脑肺血管病杂志,2019,27(1):123-125.
[14] 亢相逢,曹 玲,崔 巍,等.哮喘患儿外周血MMP-9、IFN-γ及MIP-1α水平变化及其与肺功能相关性研究[J].陕西医学杂志,2019,48(11):1464-1467.
[15] 施 利,裴 异.中医药治疗初治肺结核临床用药规律研究[J].湖南中医药大学学报,2020,275(8):112-115.
[16] 陈晶晶,张念志.中医药辅助西药治疗肺结核概述[J].山东中医药大学学报,2020,243(2):107-110.
[17] 刘 辉,王连伟,乔 飞,等.知柏地黄汤联合个体化营养支持治疗糖尿病合并肺结核疗效及对患者T淋巴细胞亚群的影响[J].陕西中医,2019,40(1):78-80.
[18] 李建生,余学庆,谢 洋.国际中医临床实践指南-慢性阻塞性肺疾病[J].世界中医药,2020,15(7):1084-1092.
[19] 刘新平,王展儒.理肺化痰通脉方治疗慢性阻塞性肺疾病急性加重期临床研究[J].陕西中医,2020,41(1):78-80.
[20] 张艳丽,都爱博,苏 军,等.自拟滋阴养肺汤治疗气阴两虚型慢性阻塞性肺疾病稳定期患者72例[J].环球中医药,2019,12(6):900-903.

相似文献/References:

[1]刘 辉,王连伟,乔 飞,等.知柏地黄汤联合个体化营养支持治疗糖尿病合并肺结核疗效及对患者T淋巴细胞亚群的影响*[J].陕西中医,2019,(1):76.
[2]任素霞,陶赟臻△,张美玲.益气消癥通络方联合西药对慢性阻塞性肺疾病急性加重期患者BODE指数及CRP的影响[J].陕西中医,2020,(7):920.[doi:DOI:10.3969/j.issn.10007369.2020.07.024]
[3]杨艳菁,蒋 玲△,李 霞.益气通络消癥汤对慢性阻塞性肺疾病患者肺功能及血清sICAM-1、MMP-9水平的影响*[J].陕西中医,2020,(9):1225.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.013]
[4]陈辅萍,彭 琦△.肺力咳胶囊联合沙丁胺醇治疗慢性阻塞性肺疾病疗效及对患者肺功能的影响[J].陕西中医,2020,(9):1228.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.014]
　CHEN Fuping,PENG Qi..Effect of Feilike capsule combined with salbutamol on chronic obstructive pulmonary disease and pulmonary function[J].,2020,(8):1228.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.014]
[5]吴 爽,王宏君,陈 琛,等.通腑益气平喘汤联合西药对慢性阻塞性肺疾病急性发作合并呼吸衰竭患者血气状态及机体微炎症反应的影响*[J].陕西中医,2020,(12):1735.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.014]
[6]李竹英,陈 璐,王丽洁.麻黄-白果药对“异病同治”支气管哮喘和慢性阻塞性肺疾病药理作用研究[J].陕西中医,2021,(8):1128.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.035]
　LI Zhuying,CHEN Lu,WANG Lijie.Pharmacological mechanism of Ephedra and Ginkgo couplet medicine in treating asthma and COPD based on treating different diseases with the same treatment[J].,2021,(8):1128.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.035]
[7]孙境孺,李竹英.NF-κB信号通路在肺部疾病中的作用研究进展及中医药干预现状[J].陕西中医,2022,(7):972.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.039]
　SUN Jingru,LI Zhuying.Research progress of role of NF-κB signaling pathway in lung diseases and the current situation of traditional Chinese medicine intervention[J].,2022,(8):972.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.039]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助面上项目(81973822); 河南省重点研发与推广专项(192102310427)
更新日期/Last Update: 2021-08-09